Kathryn Kolibaba
Sr Medical Director, Research and Development at TG Therapeutics, Inc. - New York, NY, US
Kathryn Kolibaba's Colleagues at TG Therapeutics, Inc.
Kathryn Kolibaba's Contact Details
HQ
(212) 554-4484
(212) 554-4484
Location
Yacolt, Washington, United States
Yacolt, Washington, United States
Company
TG Therapeutics, Inc.
TG Therapeutics, Inc.
Kathryn Kolibaba's Company Details
TG Therapeutics is a biopharmaceutical company focused on the acquisition, development and commercialization of novel treatments for B-cell diseases. In addition to a research pipeline including several investigational medicines, TG has completed a Phase 3 program for ublituximab, an investigational glycoengineered monoclonal antibody that targets a unique epitope on CD20-expressing B-cells, to treat patients with relapsing forms of multiple sclerosis (RMS).
Frequently Asked Questions about Kathryn Kolibaba
Kathryn Kolibaba currently works for TG Therapeutics, Inc..
Kathryn Kolibaba's role at TG Therapeutics, Inc. is Sr Medical Director, Research and Development.
Kathryn Kolibaba's email address is ***@tgtxinc.com. To view Kathryn Kolibaba's full email address, please signup to ConnectPlex.
Kathryn Kolibaba works in the BioTech/Drugs industry.
Kathryn Kolibaba's colleagues at TG Therapeutics, Inc. are Chad Sabel, Benn Richards, Daniel Gay-Betton, Christie Camelio, Adam Waldman, Dana Paskalis, Lesa Gardner and others.
Kathryn Kolibaba's phone number is (212) 554-4484